The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade.
 
Benjamin Izar
No Relationships to Disclose
 
Livnat Jerby-Arnon
No Relationships to Disclose
 
Asaf Rotem
No Relationships to Disclose
 
Parin Shah
No Relationships to Disclose
 
David Liu
No Relationships to Disclose
 
Gao Zhang
No Relationships to Disclose
 
Bastian Schilling
No Relationships to Disclose
 
Orit Rozenblatt-Rosen
No Relationships to Disclose
 
Genevieve Marie Boland
No Relationships to Disclose
 
F. Stephen Hodi
Employment - Dana-Farber Cancer Institute
Consulting or Advisory Role - Amgen; EMD Serono; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo; Strata Oncology; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Asana Biosciences; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Loxo; Merck; Novartis; Oncoceutics; Roche; Sanofi; Shattuck Labs; Tolero Pharmaceuticals
Research Funding - Novartis; Sanofi
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Genome Medical; Syapse; Tango Therapeutics
Consulting or Advisory Role - Genome Medical; InVitae; Novartis; Roche; Syapse; Takeda; Third Rock Ventures
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis
 
Bruce E. Johnson
Stock and Other Ownership Interests - KEW
Honoraria - Chugai Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; KEW; Lilly; Merck; Novartis
Research Funding - Genentech/Roche (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Toshiba (Inst)
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Charles Yoon
No Relationships to Disclose
 
Levi A. Garraway
Employment - Lilly
Stock and Other Ownership Interests - Foundation Medicine
Honoraria - Bayer
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Novartis; Third Rock Ventures; Warp Drive Bio
Research Funding - Astellas Pharma; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Bayer; Novartis; Wuxi AppTec
 
Aviv Regev
No Relationships to Disclose